BG105014A - Карбамиди и карбамати на n-хетероциклични карбонови киселини и изостери на карбонови киселини - Google Patents
Карбамиди и карбамати на n-хетероциклични карбонови киселини и изостери на карбонови киселиниInfo
- Publication number
- BG105014A BG105014A BG105014A BG10501400A BG105014A BG 105014 A BG105014 A BG 105014A BG 105014 A BG105014 A BG 105014A BG 10501400 A BG10501400 A BG 10501400A BG 105014 A BG105014 A BG 105014A
- Authority
- BG
- Bulgaria
- Prior art keywords
- carbamates
- ureas
- carboxylic acid
- acid isosteres
- carboxylic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
Изобретението се отнася до нови карбамиди и карбамати на N-хетероциклени карбоксилни киселини и изостери на карбоксилни киселини, до получаването и употребата им за лечение на неврологични заболявания, включващи физически увредени нерви и невродегенеративни заболявания, както и за лечение на алопеция и за подпомагане растежа на косата.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8784498P | 1998-06-03 | 1998-06-03 | |
PCT/US1998/025570 WO1999062879A1 (en) | 1998-06-03 | 1998-12-03 | Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
Publications (1)
Publication Number | Publication Date |
---|---|
BG105014A true BG105014A (bg) | 2001-08-31 |
Family
ID=22207585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105014A BG105014A (bg) | 1998-06-03 | 2000-12-01 | Карбамиди и карбамати на n-хетероциклични карбонови киселини и изостери на карбонови киселини |
Country Status (17)
Country | Link |
---|---|
US (2) | US20020007075A1 (bg) |
EP (1) | EP1082301A1 (bg) |
JP (1) | JP2002516903A (bg) |
KR (1) | KR20010052502A (bg) |
CN (1) | CN1299346A (bg) |
AU (1) | AU1620499A (bg) |
BG (1) | BG105014A (bg) |
BR (1) | BR9815881A (bg) |
CA (1) | CA2333960A1 (bg) |
EA (1) | EA200001246A1 (bg) |
HU (1) | HUP0102847A2 (bg) |
IL (1) | IL140039A0 (bg) |
NO (1) | NO20006111L (bg) |
PL (1) | PL348671A1 (bg) |
SK (1) | SK18292000A3 (bg) |
WO (1) | WO1999062879A1 (bg) |
ZA (1) | ZA9811061B (bg) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000302757A (ja) * | 1999-04-16 | 2000-10-31 | Shiseido Co Ltd | N−置換ピペリジン誘導体 |
JP2003504367A (ja) | 1999-07-09 | 2003-02-04 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 神経栄養性ピロリジン類およびピペリジン類、並びに関連組成物および方法 |
EP1392291B1 (en) | 2000-10-30 | 2007-05-30 | Janssen Pharmaceutica N.V. | Tripeptidyl peptidase inhibitors |
KR20140027090A (ko) | 2011-01-04 | 2014-03-06 | 노파르티스 아게 | 연령-관련 황반 변성 (amd)의 치료에 유용한 인돌 화합물 또는 그의 유사체 |
JP6209605B2 (ja) | 2012-06-28 | 2017-10-04 | ノバルティス アーゲー | ピロリジン誘導体、および補体経路調節因子としてのその使用 |
ES2647124T3 (es) | 2012-06-28 | 2017-12-19 | Novartis Ag | Derivados de pirrolidina y su uso como moduladores de la ruta del complemento |
JP6273274B2 (ja) | 2012-06-28 | 2018-01-31 | ノバルティス アーゲー | 補体経路モジュレーターおよびその使用 |
US9487483B2 (en) | 2012-06-28 | 2016-11-08 | Novartis Ag | Complement pathway modulators and uses thereof |
EP2867229B1 (en) | 2012-06-28 | 2017-07-26 | Novartis AG | Pyrrolidine derivatives and their use as complement pathway modulators |
EP2872503B1 (en) | 2012-07-12 | 2018-06-20 | Novartis AG | Complement pathway modulators and uses thereof |
WO2023090853A1 (ko) * | 2021-11-19 | 2023-05-25 | 고려대학교 세종산학협력단 | 신규 우레아계 또는 카바메이트계 p2x7 수용체 길항제 및 이를 유효성분으로 포함하는 주요 우울 장애의 예방 또는 치료용 약학 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151555A (en) * | 1979-05-14 | 1980-11-26 | Tanabe Seiyaku Co Ltd | Proline derivatives and their production |
US4402969A (en) * | 1981-03-23 | 1983-09-06 | Merck & Co., Inc. | Antihypertensive proline derivatives |
DE3134933A1 (de) * | 1981-09-03 | 1983-03-31 | Hoechst Ag, 6230 Frankfurt | "harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente sowie deren verwendung" |
JPS58170752A (ja) * | 1982-03-30 | 1983-10-07 | Kureha Chem Ind Co Ltd | N−カルバモイルアミノ酸誘導体 |
DE4228455A1 (de) * | 1992-08-26 | 1994-09-15 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Thiolen und/oder Thiolderivaten |
US5411991A (en) * | 1992-12-22 | 1995-05-02 | Shander; Douglas | Method of reducing hair growth employing sulfhydryl active compounds |
US5264619B1 (en) * | 1993-01-15 | 1996-05-14 | Cosmos Pharm Corp | Anti-androgenic cyclo and bicyclo alkenes |
US5744485A (en) * | 1994-03-25 | 1998-04-28 | Vertex Pharmaceuticals Incorporated | Carbamates and ureas as modifiers of multi-drug resistance |
US5780484A (en) * | 1996-11-13 | 1998-07-14 | Vertex Pharmaceuticals Incorporated | Methods for stimulating neurite growth with piperidine compounds |
US5935989A (en) * | 1996-12-31 | 1999-08-10 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of heterocyclic thioesters |
-
1998
- 1998-12-03 BR BR9815881-3A patent/BR9815881A/pt not_active Application Discontinuation
- 1998-12-03 IL IL14003998A patent/IL140039A0/xx unknown
- 1998-12-03 EP EP98960656A patent/EP1082301A1/en not_active Withdrawn
- 1998-12-03 PL PL98348671A patent/PL348671A1/xx unknown
- 1998-12-03 CA CA002333960A patent/CA2333960A1/en not_active Abandoned
- 1998-12-03 KR KR1020007013636A patent/KR20010052502A/ko not_active Application Discontinuation
- 1998-12-03 HU HU0102847A patent/HUP0102847A2/hu unknown
- 1998-12-03 ZA ZA9811061A patent/ZA9811061B/xx unknown
- 1998-12-03 EA EA200001246A patent/EA200001246A1/ru unknown
- 1998-12-03 SK SK1829-2000A patent/SK18292000A3/sk unknown
- 1998-12-03 WO PCT/US1998/025570 patent/WO1999062879A1/en not_active Application Discontinuation
- 1998-12-03 CN CN98814098A patent/CN1299346A/zh active Pending
- 1998-12-03 AU AU16204/99A patent/AU1620499A/en not_active Abandoned
- 1998-12-03 JP JP2000552091A patent/JP2002516903A/ja active Pending
-
2000
- 2000-12-01 BG BG105014A patent/BG105014A/bg unknown
- 2000-12-01 NO NO20006111A patent/NO20006111L/no not_active Application Discontinuation
-
2001
- 2001-01-30 US US09/771,686 patent/US20020007075A1/en not_active Abandoned
- 2001-05-03 US US09/847,432 patent/US20020042442A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999062879A1 (en) | 1999-12-09 |
EA200001246A1 (ru) | 2001-08-27 |
KR20010052502A (ko) | 2001-06-25 |
US20020007075A1 (en) | 2002-01-17 |
JP2002516903A (ja) | 2002-06-11 |
US20020042442A1 (en) | 2002-04-11 |
CA2333960A1 (en) | 1999-12-09 |
HUP0102847A2 (hu) | 2001-12-28 |
CN1299346A (zh) | 2001-06-13 |
ZA9811061B (en) | 1999-12-03 |
AU1620499A (en) | 1999-12-20 |
BR9815881A (pt) | 2002-07-23 |
PL348671A1 (en) | 2002-06-03 |
NO20006111L (no) | 2001-02-01 |
SK18292000A3 (sk) | 2001-07-10 |
NO20006111D0 (no) | 2000-12-01 |
WO1999062879A8 (en) | 2000-05-04 |
IL140039A0 (en) | 2002-02-10 |
EP1082301A1 (en) | 2001-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG105012A (bg) | N-свързани сулфонамиди на n-хетероциклични карбонови киселини или изостери на карбонови киселини | |
BG105643A (bg) | Карбонови киселини и изостери на карбонови киселини на n-хетероциклични съединения | |
MY115977A (en) | Synthetic excitatory amino acids | |
MY131442A (en) | Excitatory amino acid receptor antagonists | |
PL342078A1 (en) | Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas | |
GB2305605B (en) | Pipecolic acid derivatives for the treatment of neurological disorders | |
BRPI0015533B8 (pt) | enzima alfa-l-iduronidase humana recombinante, composição farmacêutica compreendendo a mesma e método para sua purificação | |
RU93049265A (ru) | Производные декагидроизохинолинов, способ получения, фармацевтическая композиция | |
ATE552891T1 (de) | Kombination von sauren-proteaseenzymen und sauren pufferlösungen sowie deren verwendung | |
HUP9701193A3 (en) | Use of n-(4-aryl-thiazol-2-yl)-sulfonamide derivatives for the preparation of pharmaceutical compositions treating neurological disorders, new derivatives, process for their preparation and pharmaceutical compositions containing them | |
IL132293A0 (en) | Use of lactoferin in the treatment of allergen induced disorders | |
BG105014A (bg) | Карбамиди и карбамати на n-хетероциклични карбонови киселини и изостери на карбонови киселини | |
IE902288L (en) | Tetrazolylmethylpiperidine carboxylic acid | |
ATE319712T1 (de) | Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung | |
HUT66309A (en) | Bpc peptides, their preparation and therapeutic use | |
BR9815919A (pt) | Compostos aza heterocìclicos usados para tratar distúrbios neurológicos e perda de cabelo | |
DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
DE59708511D1 (de) | Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen | |
RS20050366A (en) | A method for preparing indan-1,3- dicarboxylic acid | |
WO2000061180A3 (en) | Products and methods for treating ptp lar related diseases | |
TW200600512A (en) | Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |